Breaking News Instant updates and real-time market news.

LITE

Lumentum

$51.68

-1.45 (-2.73%)

, AAOI

Applied Optoelectronics

$9.58

-0.25 (-2.54%)

09:28
07/09/19
07/09
09:28
07/09/19
09:28

Optical components makers rally after Cisco acquires Acacia for 46% premium

After Cisco Systems (CSCO) this morning announced the acquisition of Acacia Communications (ACIA) for a 46% premium, or $70 per share in cash, shares of optical components makers are moving higher. Lumentum (LITE), Applied Optoelectronics (AAOI), NeoPhotonics (NPTN), Finisar (FNSR), Ciena (CIEN) and Infinera (INFN) are among the names set to open higher.

LITE

Lumentum

$51.68

-1.45 (-2.73%)

AAOI

Applied Optoelectronics

$9.58

-0.25 (-2.54%)

NPTN

NeoPhotonics

$4.28

-0.07 (-1.61%)

FNSR

Finisar

$22.94

-0.26 (-1.12%)

CIEN

Ciena

$42.08

-0.9 (-2.09%)

INFN

Infinera

$2.82

-0.17 (-5.69%)

CSCO

Cisco

$56.20

-0.41 (-0.72%)

ACIA

Acacia Communications

$48.13

0.05 (0.10%)

  • 09

    Jul

  • 09

    Jul

  • 09

    Jul

  • 10

    Jul

  • 16

    Jul

  • 17

    Jul

  • 14

    Aug

LITE Lumentum
$51.68

-1.45 (-2.73%)

07/09/19
RILY
07/09/19
NO CHANGE
RILY
B. Riley FBR says China supply chain internalization issue for optical industry
B. Riley FBR analyst Dave Kang lowered his price target for Lumentum (LITE) to $68 from $74 and for Inphi (IPHI) to $45 from $47. While the ban on Huawei has garnered investor attention recently, the bigger issue for the optical industry could be China's internalization of its supply chain, which has been accelerated due to the recent ban, Kang tells investors in a research note. The analyst believes that even after the partial reprieve on Huawei, the U.S. optical companies may not fully recover to the previous levels with Huawei. Recent channel checks revealed that Huawei has significantly accelerated the internalization process of its supply chain, adds the analyst. As a result, he believes the U.S. optical industry is facing "collateral damage" from the trade war with China. Kang keeps a Buy rating on Lumentum and Neutral rating on Inphi. He favors Huawei's competitors such as Ciena (CIEN) and Dasan Zhone Solutions (DZSI), which he believes could gain market share from international customers diversifying away from Huawei.
07/02/19
PIPR
07/02/19
NO CHANGE
PIPR
Piper sees 'interesting opportunities' in Optical Networking space
The trade war concerns have created some "interesting opportunities" within the Optical Networking space as underlying demand trends remain solid, Piper Jaffray analyst Troy Jensen tells investors in a research note. The analyst believes investors should revisit some select names and he highlights Acacia Communications (ACIA), Fabrinet (FN) and Lumentum (LITE). He continues to view Acacia as one of the best optical stocks to own and would be buyers at current levels.
06/06/19
LEHM
06/06/19
NO CHANGE
Target $50
LEHM
Overweight
Lumentum price target lowered to $50 from $60 at Barclays
Barclays analyst Blayne Curtis lowered his price target for Lumentum to $50 from $60 citing an "increasingly weaker market." The analyst, however, keeps an Overweight rating on the shares.
05/30/19
JPMS
05/30/19
NO CHANGE
JPMS
JPMorgan views Cisco, Ciena as 'safe havens' during trade war
The vast majority of the multiple de-rating in the Networking/IT Hardware sector has been driven by investor concerns relative to the recent escalation in the trade stand-off with China, and investors are mindful of stocks with high exposure to China and/or Huawei, JPMorgan analyst Samik Chatterjee tells investors in a research note. The analyst continues to recommend Cisco Systems (CSCO) as his top pick for investors as a "relative safe haven," along with Ciena (CIEN), as he believes the company's upcoming fiscal Q2 results will likely be a catalyst. Beyond these names, Chatterjee sees a favorable set up for Neutral-rated Arista Networks (ANET) and he continues to recommend Overweight-rated Lumentum (LITE), despite its high exposure to both China and Huawei.
AAOI Applied Optoelectronics
$9.58

-0.25 (-2.54%)

04/09/19
PIPR
04/09/19
NO CHANGE
Target $11
PIPR
Neutral
Applied Optoelectronics estimates and price target lowered at Piper Jaffray
Piper Jaffray analyst Troy Jensen lowered his estimates and price target for Applied Optoelectronics as he believes pricing pressure and weakened demand trends for datacom transceivers have persisted in the first half of 2019. Further, the company's exposure to 10/40G and high customer concentration creates additional risk and the likelihood of sustained pricing pressure, Jensen tells investors in a research note. He believes 2020 could be a better year for Applied Optoelectronics with anticipated growth in 100G, but feels near-term weakness will likely create pressure on the shares. As such, the analyst recommends avoiding the name and lowered his price target to $11 from $12. He keeps a Neutral rating on Applied Optoelectronics.
02/22/19
02/22/19
DOWNGRADE
Target $16

Neutral
Applied Optoelectronics downgraded to Neutral from Buy at DA Davidson
As previously reported, DA Davidson analyst Mark Kelleher downgraded Applied Optoelectronics to Neutral and lowered his price target to $16 from $42 after its worse than expected Q1 guidance, citing the company's "muted visibility" toward revenue growth and rising inventory levels at data center customers. The analyst notes that while the issue around 25G lasers had been resolved, capacity has been constrained further by the company's addition of testing steps to screen existing inventory. Kelleher adds that the inventory congestion in the data center market and poor visibility in China are "significant issues" that will take "at least a couple quarters to resolve".
02/22/19
NEED
02/22/19
DOWNGRADE
NEED
Hold
Applied Optoelectronics downgraded to Hold from Buy at Needham
06/27/19
RSBL
06/27/19
UPGRADE
Target $10
RSBL
Neutral
Applied Optoelectronics upgraded to Neutral from Sell at Rosenblatt
Rosenblatt analyst Jun Zhang upgraded Applied Optoelectronics to Neutral from Sell with a $10 price target.
NPTN NeoPhotonics
$4.28

-0.07 (-1.61%)

05/20/19
RILY
05/20/19
UPGRADE
Target $5.5
RILY
Buy
NeoPhotonics upgraded to Buy from Neutral at B. Riley FBR
B. Riley FBR analyst David Kang upgraded NeoPhotonics to Buy from Neutral while lowering his price target for the shares to $5.50 from $7.25. The company's exposure to Huawei has been "de-risked" following the recent selloff in the shares, Kang tells investors in a research note. He reduced his estimates for NeoPhotonics but upgraded to the shares to Buy.
05/20/19
05/20/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. General Dynamics (GD) upgraded to Buy from Neutral at Goldman Sachs with analyst Noah Poponak saying the valuation of General Dynamics relative to its defense peers has moved to the low-end of historical ranges. 2. Target (TGT) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Simeon Gutman citing his view that the 15% pullback in the stock over the past month leaves less near-term downside and that the company "appears to be past peak margin pain." 3. NeoPhotonics (NPTN) upgraded to Buy from Neutral at B. Riley FBR with analyst David Kang saying the company's exposure to Huawei has been "de-risked" following the recent selloff in the shares. 4. United Continental (UAL) upgraded to Overweight from Equal Weight at Morgan Stanley. 5. Jack in the Box (JACK) upgraded to Buy from Hold at Stifel with analyst Chris O'Cull saying the stock's valuation will improve as investors gain confidence in the company's outlook. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/24/19
CHLM
05/24/19
NO CHANGE
Target $6
CHLM
Buy
NeoPhotonics price target lowered to $6 from $11 at Craig-Hallum
Craig-Hallum analyst Richard Shannon lowered his price target for NeoPhotonics to $6 from $11 and maintained a Buy rating following the company's lowered Q2 guidance, which implies Huawei would only represent 32% of sales, which is lower than 49% in Q1 and 45% in 2018, suggesting a lower ongoing contribution the rest of the year as other customers grow more. In a research note to investors, the analyst says the stock has more than taken into account the risk of these Huawei issues.
05/28/19
NEED
05/28/19
NO CHANGE
Target $62
NEED
Buy
Fabrinet price target lowered to $62 from $70 at Needham
Needham analyst Alex Henderson lowered his price target on Fabrinet (FN) to $62 to reflect the company's loss of sales to Huawei on the expected impact to Lumentum (LITE) - one of Fabrinet's largest customers. The analyst notes that although Huawei is not a direct Fabrinet customer, between Lumentum and NeoPhotonics (NPTN), about 10% of its revenue is tied to Huawei through its customers. Henderson still keeps his Buy rating on the stock with an optimistic view that a trade deal between U.S. and China will be reached "at some point."
FNSR Finisar
$22.94

-0.26 (-1.12%)

03/01/19
PIPR
03/01/19
NO CHANGE
Target $24.5
PIPR
Overweight
Finisar revenue growth remains 'elusive,' says Piper Jaffray
Finisar last night reported December quarter results similar to last quarter with earnings upside but revenues below consensus, Piper Jaffray analyst Troy Jensen tells investors in a research note. The company made improvements in gross margins, but given greater than 70% of its sales are datacom related and the segment continues to see weakness, Jensen adds. As such, "solid revenue growth remains elusive," he says. The analyst maintains a Buy rating on Finisar shares with a $24.50 price target.
05/01/19
PIPR
05/01/19
NO CHANGE
Target $50
PIPR
Overweight
II-VI Q3 results show 'strong optical demand', says Piper Jaffray
Piper Jaffray analyst Troy Jensen kept his Overweight rating and $50 price target on II-VI (IIVI) after its Q3 results, saying its Q3 earnings miss was driven by slower than expected 3D sensing revenue growth, even though the demand for its optical business remained strong. The analyst still believes that 3D sensing will be a tailwind for II-VI longer term and also sees its Finisar (FNSR) acquisition tracking according to plan toward a closing in 2-3 months.
05/02/19
CHLM
05/02/19
NO CHANGE
Target $54
CHLM
Buy
II-VI price target raised to $54 from $47 at Craig-Hallum
Craig-Hallum analyst Richard Shannon raised his price target for II-VI (IIVI) to $54 from $47, assuming the company will close Finisar (FNSR) and based on his projected 2021 EPS for the combined entity. The analyst reiterates a Buy rating on II-VI shares.
06/14/19
MKMP
06/14/19
NO CHANGE
Target $23
MKMP
Neutral
Finisar price target lowered to $23 from $25 at MKM Partners
MKM Partners analyst Michael Genovese lowered his price target on Finisar to $23 and kept his Neutral rating after its mixed Q4 results with "soft" revenues and solid earnings. The analyst attributes the shortfall to the "ongoing weakness" in 100G datacom module pricing and also lowers his FY20 EPS view to $1.09 from $1.37 to account for Huawei sales loss, but also believes that the company's Telecom business was likely solid and its 3D Sensing performance was "okay".
CIEN Ciena
$42.08

-0.9 (-2.09%)

07/01/19
NEED
07/01/19
UPGRADE
Target $59
NEED
Buy
Acacia Communications upgraded to Buy from Hold at Needham
Needham analyst Alex Henderson upgraded Acacia Communications (ACIA) to Buy from Hold with a $59 price target following a round of industry checks and visits. In a research note to investors, Henderson says he believes the landscape is improving for Acacia, as well as for Ciena (CIEN) and Infinera (INFN). By driving more rapid new DSP introductions, the analyst says Acacia has pressured its competitors to keep pace, which he says they are not. He thinks Acacia will gain share, lock in customers, and enhance their advantage on the next chip development cycle.
06/07/19
RILY
06/07/19
NO CHANGE
Target $55
RILY
Buy
Ciena price target raised to $55 from $48 at B. Riley FBR
B. Riley FBR analyst Dave Kang raised his price target for Ciena to $55 from $48 saying the company is outpacing the industry with market share gains. He keeps a Buy rating on the shares following Ciena's fiscal Q2 results.
06/07/19
JEFF
06/07/19
NO CHANGE
Target $55
JEFF
Buy
Ciena price target raised to $55 from $50 at Jefferies
Jefferies analyst George Notter raised his price target for Ciena to $55 from $50 saying the company's April quarter results reinforced his view that the company is the long-term share consolidator in the space. He thinks the shares remain "too cheap" as the Street is still underestimating Ciena's ability to grow market share over time. The analyst keeps a Buy rating on the name.
INFN Infinera
$2.82

-0.17 (-5.69%)

06/03/19
06/03/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Infinera (INFN) downgraded to Underweight from Neutral at JPMorgan with analyst Samik Chatterjee saying he sees a "heightened level of near-term and medium-term risks from the much more moderate level" of capex spending from cable customers. 2. Cree (CREE) downgraded to Market Perform from Outperform at BMO Capital with analyst Ambrish Srivastava saying he believes Cree is executing solidly on its transformation but finds the stock's risk/reward profile as fairly balanced at current levels. 3. Fortive (FTV) downgraded to Underperform from Market Perform at Cowen. 4. Big Lots (BIG) double downgraded to Underperform from Buy at BofA/Merrill with analyst Jason Haas saying the company's outlook for the rest of the year may be too optimistic and could be cut further. 5. Emerald Expositions Events (EEX) downgraded to Neutral from Buy at Goldman Sachs. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/03/19
JPMS
06/03/19
DOWNGRADE
JPMS
Underweight
JPMorgan downgrades Infinera to Underweight on slowing cable spending
JPMorgan analyst Samik Chatterjee downgraded Infinera to Underweight from Neutral without a price target. The analyst sees a "heightened level of near-term and medium-term risks from the much more moderate level" of capex spending from cable customers. This is in addition to the already existing long-term risks relative to the acquisition, Chatterjee tells investors in a research note.
06/03/19
JPMS
06/03/19
DOWNGRADE
JPMS
Underweight
Infinera downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Samik Chatterjee downgraded Infinera to Underweight from Neutral.
CSCO Cisco
$56.20

-0.41 (-0.72%)

06/12/19
06/12/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Cisco (CSCO) downgraded to Market Perform from Outperform at William Blair with analyst Jason Ader saying he sees "signs of tightening demand" across IT infrastructure, which he believes could pressure growth in Cisco's fiscal 2020, "especially when compared against unusually strong demand in fiscal 2019." 2. Manpower (MAN) downgraded to Neutral from Outperform at Credit Suisse. 3. Dave & Buster's (PLAY) downgraded to Hold from Buy at Gordon Haskett and SunTrust, as well as to Market Perform from Outperform at Wells Fargo. 4. Amcor (AMCR) reinstated with a Sell from Neutral at Goldman Sachs with analyst Brian Maguire saying Bemis's earnings growth "has not proven to be as resilient in recent years." 5. Beyond Meat (BYND) downgraded to Market Perform from Outperform at Bernstein with analyst Alexia Howard saying "valuation considerations as the stock has traded in a highly volatile manner since its IPO likely due to its limited public float." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/25/19
COWN
06/25/19
NO CHANGE
COWN
Outperform
Cisco remains our "Best idea", says Cowen
Cowen analyst Paul Silverstein said Cisco remains his "Best idea" for 2019. He cited confidence in its earnings power from an improving comps position, ongoing shift to recurring software revenue, and increasing strategic significance of the network. Silverstein reiterated his Outperform rating and $65 price target on Cisco shares.
07/03/19
RILY
07/03/19
NO CHANGE
Target $5
RILY
Buy
Finjan kept 'all-important' system claims in patent ruling, says B. Riley FBR
The U.S. Court of Appeals for the Federal Circuit yesterday affirmed prior U.S. Patent Trial and Appeal Board inter partes review rulings that affirm the patentability of claims of one of Finjan Holdings' (FNJN) workhorse patents against Palo Alto Networks, B. Riley FBR analyst Mike Crawford tells investors in a research note. While Finjan didn't regain prior stricken method claims, it did retain its "all-import" system claims in the patent, says the analyst. Further, he believes the CAFC cleared up an unintentional delay on delayed priority claim issue that quashes any inequitable conduct arguments not only in the Palo Alto case but also in others such as Juniper Networks (JNPR) and Cisco Systems (CSCO) where Finjan also is asserting this patent. Crawford now expects Finjan to ask the judge to lift the stay, "setting the wheels in motion to grind toward a potential jury trial." He keeps a Buy rating on the shares with a $5 price target.
07/08/19
SBSH
07/08/19
DOWNGRADE
Target $24
SBSH
Sell
Juniper downgraded to Sell from Neutral at Citi
Citi analyst Jim Suva downgraded Juniper Networks (JNPR) to Sell from Neutral and cut his price target for the shares to $24 from $28. The analyst has picked up recent competitive share gains by Arista Networks (ANET) and Cisco Systems (CSCO). This sets up for more share loss to Juniper and "too lofty" expectations in the second half of 2019, Suva tells investors in a research note.
ACIA Acacia Communications
$48.13

0.05 (0.10%)

07/01/19
NEED
07/01/19
UPGRADE
NEED
Buy
Acacia Communications upgraded to Buy from Hold at Needham
05/06/19
05/06/19
UPGRADE
Target $64

Neutral
Acacia Communications upgraded to Neutral at BofA/Merrill
As previously reported, BofA/Merrill upgraded Acacia Communications to Neutral from Underperform and raised its price target to $64 from $40. Analyst Tal Liani believes Acacia is well positioned to benefit from China's 5G build-out and new Data Center products, but notes customer concentration is a key risk given Chinese vendor inventory build-out.

TODAY'S FREE FLY STORIES

16:39
07/16/19
07/16
16:39
07/16/19
16:39
General news
API crude inventories for week of July 12 »

API reports that crude…

HOPE

Hope Bancorp

$13.96

0.2 (1.45%)

16:37
07/16/19
07/16
16:37
07/16/19
16:37
Earnings
Hope Bancorp reports Q2 EPS 34c, consensus 34c »

Net interest income…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

INO

Inovio

$3.00

0.05 (1.69%)

16:35
07/16/19
07/16
16:35
07/16/19
16:35
Hot Stocks
Breaking Hot Stocks news story on Inovio 

Inovio trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMRN

Immuron

$4.27

1.43 (50.35%)

16:32
07/16/19
07/16
16:32
07/16/19
16:32
Syndicate
Immuron files to sell American Depositary Shares, no amount given »

ThinkEquity, a division…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JPM

JPMorgan

$115.10

1.23 (1.08%)

, GS

Goldman Sachs

$215.57

4.02 (1.90%)

16:32
07/16/19
07/16
16:32
07/16/19
16:32
On The Fly
Fly Intel: Wall Street's top stories for Tuesday »

The major averages were…

JPM

JPMorgan

$115.10

1.23 (1.08%)

GS

Goldman Sachs

$215.57

4.02 (1.90%)

JNJ

Johnson & Johnson

$132.46

-2.21 (-1.64%)

WFC

Wells Fargo

$45.30

-1.4 (-3.00%)

ARW

Arrow Electronics

$67.67

-1.15 (-1.67%)

TSLA

Tesla

$252.38

-1.03 (-0.41%)

APRN

Blue Apron

$10.33

2.68 (35.03%)

BYND

Beyond Meat

$172.50

5.9 (3.54%)

JBHT

J.B. Hunt

$97.76

5.26 (5.69%)

QTT

Qutoutiao

$4.31

-0.22 (-4.86%)

DPZ

Domino's Pizza

$246.55

-23.42 (-8.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 18

    Jul

  • 24

    Jul

  • 29

    Jul

  • 06

    Aug

  • 06

    Aug

  • 06

    Aug

  • 26

    Aug

  • 09

    Sep

  • 16

    Sep

  • 12

    Oct

  • 13

    Nov

PBYI

Puma Biotechnology

$10.78

-0.42 (-3.75%)

16:32
07/16/19
07/16
16:32
07/16/19
16:32
Hot Stocks
Knight says Health Canada approves NERLYNX for early-stage breast cancer »

Knight Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FULT

Fulton Financial

$16.31

0.11 (0.68%)

16:31
07/16/19
07/16
16:31
07/16/19
16:31
Earnings
Fulton Financial reports Q2 EPS 35c, consensus 34c »

Net interest income for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 06

    Aug

  • 07

    Aug

  • 03

    Sep

  • 05

    Sep

WAIR

Wesco Aircraft

$10.84

0.085 (0.79%)

16:30
07/16/19
07/16
16:30
07/16/19
16:30
Hot Stocks
Wesco Aircraft expans business with GKN Aerospace »

Wesco Aircraft Holdings,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
07/16/19
07/16
16:30
07/16/19
16:30
Options
Preliminary option volume of 17.5M today »

Preliminary option volume…

UBNK

United Financial

$14.07

0.05 (0.36%)

16:27
07/16/19
07/16
16:27
07/16/19
16:27
Earnings
United Financial reports Q2 EPS (6c), consensus 24c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

ERYP

Erytech Pharma

$6.69

(0.00%)

16:24
07/16/19
07/16
16:24
07/16/19
16:24
Syndicate
Erytech Pharma files to sell $100M of ADSs »

Representing ordinary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSX

CSX

$79.57

1.05 (1.34%)

16:23
07/16/19
07/16
16:23
07/16/19
16:23
Earnings
CSX sees FY19 revenue down 1%-2% vs. prior view of growth »

CSX sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 26

    Aug

  • 13

    Nov

INAP

Internap

$3.56

0.13 (3.79%)

16:22
07/16/19
07/16
16:22
07/16/19
16:22
Hot Stocks
Internap to streamline organization, initiates search for new CFO »

Internap announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FNF

Fidelity National

$41.57

0.02 (0.05%)

16:21
07/16/19
07/16
16:21
07/16/19
16:21
Earnings
Fidelity National reports Q2 adjusted EPS 92c, consensus 87c »

Reports Q2 revenue $2.1B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 01

    Aug

  • 13

    Nov

RM

Regional Management

$26.62

-0.28 (-1.04%)

16:20
07/16/19
07/16
16:20
07/16/19
16:20
Hot Stocks
Regional Management appoints Robert Beck CFO »

Regional Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
07/16/19
07/16
16:20
07/16/19
16:20
Options
Closing CBOE SPX and VIX Index summary for July 16th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLL

Whiting Petroleum

$15.54

-0.65 (-4.01%)

16:19
07/16/19
07/16
16:19
07/16/19
16:19
Hot Stocks
Whiting Petroleum names Correne S. Loeffler CFO »

Whiting Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

  • 27

    Aug

UAL

United Continental

$94.00

2.7 (2.96%)

16:19
07/16/19
07/16
16:19
07/16/19
16:19
Hot Stocks
Breaking Hot Stocks news story on United Continental »

United Continental…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

CSX

CSX

$79.57

1.05 (1.34%)

16:19
07/16/19
07/16
16:19
07/16/19
16:19
Hot Stocks
Breaking Hot Stocks news story on CSX »

CSX Q2 CapEx down to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 26

    Aug

  • 13

    Nov

BPMX

BioPharmX

$0.44

-0.0183 (-3.97%)

16:19
07/16/19
07/16
16:19
07/16/19
16:19
Hot Stocks
BioPharmX appoints Steven Bosacki COO »

BioPharmX Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCCL

China Ceramics

$0.87

(0.00%)

16:18
07/16/19
07/16
16:18
07/16/19
16:18
Hot Stocks
China Ceramics receives Nasdaq notification of non-compliance »

China Ceramics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$94.00

2.7 (2.96%)

16:18
07/16/19
07/16
16:18
07/16/19
16:18
Hot Stocks
United Continental reports Q2 total passenger revenue up 6.1% y/y »

Consolidated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

VNDA

Vanda Pharmaceuticals

$13.45

-0.13 (-0.96%)

16:18
07/16/19
07/16
16:18
07/16/19
16:18
Hot Stocks
Vanda Pharmaceuticals announces study results for tradipitant »

Vanda Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

STIM

Neuronetics

$12.65

-0.2 (-1.56%)

, UNH

UnitedHealth

$264.60

-1.31 (-0.49%)

16:18
07/16/19
07/16
16:18
07/16/19
16:18
Recommendations
Neuronetics, UnitedHealth analyst commentary  »

UnitedHealth coverage…

STIM

Neuronetics

$12.65

-0.2 (-1.56%)

UNH

UnitedHealth

$264.60

-1.31 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

CTAS

Cintas

$239.46

-3.85 (-1.58%)

16:17
07/16/19
07/16
16:17
07/16/19
16:17
Earnings
Cintas sees FY20 EPS $8.30-$8.45, consensus $8.32 »

Sees FY20 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.